Springfield, OREGON4 Active Studies

Ankylosing Spondylitis Clinical Trials in Springfield, OREGON

Find 4 actively recruiting ankylosing spondylitis clinical trials in Springfield, OREGON. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
3,253
Enrolling

Recruiting Ankylosing Spondylitis Studies in Springfield

RecruitingSpringfield, OREGONNCT06422689

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

ANCHOR is a prospective, multi-center, phase IV, interventional, single-arm, open-label study of 2,000 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare t...

2,000 participants
AstraZeneca
View Study Details
RecruitingSpringfield, OREGONNCT03671044

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

The Nanosomal Docetaxel Lipid Suspension (NDLS) consists of uniformly sized micro particles of docetaxel suspended in a lipid based formulation. The advantage of such a Lipid Based formulation of Doce...

657 participants
Jina Pharmaceuticals Inc.
View Study Details
RecruitingSpringfield, OREGONNCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

This study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a CDK4/6i and letrozole i...

450 participants
Hoffmann-La Roche
View Study Details
RecruitingSpringfield, OREGONNCT06517758

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.

The study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in patients with AChR+ gMG who are on stable SOC t...

146 participants
Novartis Pharmaceuticals
View Study Details

About Ankylosing Spondylitis Clinical Trials in Springfield

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Springfield, OREGON. These studies are seeking a combined 3,253 participants. Research is being sponsored by AstraZeneca, Jina Pharmaceuticals Inc., Hoffmann-La Roche and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Springfield — FAQ

Are there ankylosing spondylitis clinical trials in Springfield?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Springfield, OREGON. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Springfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Springfield research site will contact you about next steps.

Are clinical trials in Springfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Springfield studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Springfield are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov